SSRI prescription during acute COVID-19 and risk of Long COVID symptoms and conditions among patients with depression. Journal Abstract - Guideline Central

SSRI prescription during acute COVID-19 and risk of Long COVID symptoms and conditions among patients with depression.

Published: 2026 Jul 09

Authors

, , , , , , , , ,

Abstract

Long COVID is a syndrome characterized by symptoms and conditions across all biological systems. This breadth of Long COVID phenotypes impedes efforts to identify the mechanistic pathways of Long COVID. Low serotonin may play a role in long-term sequelae of COVID-19, and selective serotonin reuptake inhibitors (SSRIs) may prevent these sequelae. Evaluation of the relationship between SSRIs and distinct categories of symptoms and conditions associated with Long COVID can highlight the mechanistic pathways that drive these relationships.

Source

medRxiv : the preprint server for health sciences

Publication Type

Journal Article

Language

English

PubMed ID

42465882

You rely on Guideline Central for transparency

Guideline Central and select third party use “cookies” on this website to enhance the user experience.

This technology helps us gather statistical and analytical information to optimize the relevant content for you.

The user also has the option to opt-out which may have an effect on the browsing experience.